Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for …
$1.69+0.60%
报价 2026-11-13
市值
$4.5M
EV
–
PE (TTM)
–
预期 PE
–
52 周区间距高点 -79.9%
$1.60$8.41
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares | $4.5M | +0.6% | – | -1.3% | – | – | – | |
| ADXNAddex Therapeutics Ltd | $5M | -23.3% | – | 41.2% | – | – | – | |
| SKYESkye Bioscience, Inc. | $4.8M | +0.9% | – | 0% | – | – | – | |
| PULMPulmatrix, Inc. | $4.7M | -0.8% | +135.7% | 0% | – | – | – | |
| GTBPGT Biopharma, Inc. | $4.7M | -3.0% | -28.1% | 0% | – | – | – | |
| SNTISenti Biosciences, Inc. | $4.4M | -4.8% | +150.0% | -2,736.4% | – | – | – | |
| CNSPCNS Pharmaceuticals, Inc. | $4.2M | -20.2% | +75.9% | 0% | – | – | – | |
| LIMNIris Acquisition Corp | $4M | +7.9% | – | 0% | – | – | – | |
| CELZCreative Medical Technology Holdings, Inc. | $4M | -14.4% | +779900.0% | -1,732.4% | – | – | – | |
| 同行中位数 | – | – | +135.7% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
报告货币 SGD（非美元）暂无季度数据（首次研究运行后填充）。